Viewing Study NCT00303992


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-27 @ 10:01 AM
Study NCT ID: NCT00303992
Status: COMPLETED
Last Update Posted: 2018-01-17
First Post: 2006-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer
Sponsor: University of California, San Francisco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module